Related Experiment Video
Updated: Feb 14, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia
Fiona C Brown1, Eric Still1, Richard P Koche2
1Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.
Abstract:
In acute myeloid leukemia (AML), chemotherapy resistance remains prevalent and poorly understood. Using functional proteomics of patient AML specimens, we identified MEF2C S222 phosphorylation as a specific marker of primary chemoresistance. We found that Mef2c knock-in mutant mice engineered to block MEF2C phosphorylation exhibited normal hematopoiesis, but were resistant to leukemogenesis induced by MLL-AF9 MEF2C phosphorylation was required for leukemia stem cell maintenance and induced by MARK kinases in cells. Treatment with the selective MARK/SIK inhibitor MRT199665 caused apoptosis and conferred chemosensitivity in MEF2C-activated human AML cell lines and primary patient specimens, but not those lacking MEF2C phosphorylation. These findings identify kinase-dependent dysregulation of transcription factor control as a determinant of therapy response in AML, with immediate potential for improved diagnosis and therapy for this disease.Significance: Functional proteomics identifies phosphorylation of MEF2C in the majority of primary chemotherapy-resistant AML. Kinase-dependent dysregulation of this transcription factor confers susceptibility to MARK/SIK kinase inhibition in preclinical models, substantiating its clinical investigation for improved diagnosis and therapy of AML. Cancer Discov; 8(4); 478-97. ©2018 AACR.This article is highlighted in the In This Issue feature, p. 371.
Insights
Chemotherapy resistance in acute myeloid leukemia (AML) is linked to MEF2C phosphorylation. Inhibiting MARK/SIK kinases with MRT199665 shows promise for treating resistant AML by targeting this pathway.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Chemotherapy resistance is a major challenge in treating acute myeloid leukemia (AML).
- The underlying mechanisms of primary chemoresistance in AML are not fully understood.
Purpose of the Study:
- To identify molecular markers and therapeutic targets for chemoresistant AML.
- To investigate the role of MEF2C phosphorylation in AML chemoresistance and leukemogenesis.
Main Methods:
- Functional proteomics was employed on patient AML specimens.
- MEF2C phosphorylation status was analyzed in relation to chemoresistance.
- Mice with engineered MEF2C mutations were used to study leukemogenesis.
- The effects of MARK/SIK inhibitor MRT199665 were tested on AML cell lines and patient samples.
Main Results:
- MEF2C S222 phosphorylation was identified as a specific marker of primary chemoresistance in AML.
- MEF2C phosphorylation is essential for leukemia stem cell maintenance and is induced by MARK kinases.
- Inhibition of MARK/SIK kinases with MRT199665 induced apoptosis and chemosensitivity in MEF2C-activated AML, but not in others.
- These findings highlight kinase-dependent transcription factor dysregulation as a determinant of AML therapy response.
Conclusions:
- MEF2C phosphorylation is a key determinant of therapy response in AML.
- Targeting MARK/SIK kinases offers a potential therapeutic strategy for chemoresistant AML.
- This research provides a basis for improved diagnosis and treatment of AML.
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Energy-requiring Steps of Glycolysis
Requirements for Human Life
Oxygen
Atmospheric air is only about 20 percent oxygen, but that oxygen is a key component of the chemical reactions that keep the body alive, including the reactions that produce ATP. Brain cells are susceptible to a lack of oxygen because they require a...
Proteins: Dietary Sources and Requirements
Oxygen Requirements and Growth Patterns
Resistivity

